血浆胱抑素C对冠心病的预后价值评估(3)
[8] Koenig W，Twardella D，Brenner H，Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events： more than simply a marker of glomerular filtration rate[J]. Clin Chem， 2005，51(2)：321-327.
[9] Jernberg T，Lindahl B，James S，et al. Cystatin C：a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome[J]. Circulation，2004，110(16)：2342-2348.
[10] Manzano-Fernández S，López-Cuenca A，Januzzi JL，et al. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes[J]. Am J Cardiol，2012，110(9)：1240-1248.
[11] Niccoli G，Conte M，Della Bona R，et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate[J]. Atherosclerosis，2008，1989(2)：373-380.
[12] 李庆，王聪霞，董 新，等. 血清胱抑素C、高敏C 反应蛋白与冠状动脉粥样硬化斑块负荷的关系[J]. 西安交通大学学报(医学版)，2012，33(1)：43-47.
(收稿日期：2012-12-10)
, 百拇医药(吴梅芳 林丽明等)
[9] Jernberg T，Lindahl B，James S，et al. Cystatin C：a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome[J]. Circulation，2004，110(16)：2342-2348.
[10] Manzano-Fernández S，López-Cuenca A，Januzzi JL，et al. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes[J]. Am J Cardiol，2012，110(9)：1240-1248.
[11] Niccoli G，Conte M，Della Bona R，et al. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate[J]. Atherosclerosis，2008，1989(2)：373-380.
[12] 李庆，王聪霞，董 新，等. 血清胱抑素C、高敏C 反应蛋白与冠状动脉粥样硬化斑块负荷的关系[J]. 西安交通大学学报(医学版)，2012，33(1)：43-47.
(收稿日期：2012-12-10)
, 百拇医药(吴梅芳 林丽明等)